SCHEMBL18623300

SCHEMBL18623300

c1ccc(-c2cc(-c3ccccc3)nc(-c3ccc(-c4ccc(-c5nc(-c6cccc7ccccc67)nc(-c6cccc7ccccc67)n5)c5ccccc45)c4ccccc34)n2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.49
▸ HPGD P15428 7/20 0.49
▸ MAPT P10636 7/20 0.49
▸ KDM4E B2RXH2 5/20 0.49
▸ SMN1; SMN2 Q16637 4/20 0.49
▸ L3MBTL1 Q9Y468 2/20 0.49
▸ TDP1 Q9NUW8 2/20 0.49
▸ TP53 P04637 2/20 0.49
▸ MAPK1 P28482 2/20 0.49
▸ HSD17B10 Q99714 2/20 0.49
▸ TSHR P16473 1/20 0.49
▸ NFKB1 P19838 1/20 0.49
▸ NFKB2 Q00653 1/20 0.49
▸ RELA Q04206 1/20 0.49
▸ ATM Q13315 1/20 0.49
▸ MEN1 O00255 9/20 0.47
▸ KMT2A Q03164 9/20 0.47
▸ LMNA P02545 3/20 0.45
▸ GLA P06280 1/20 0.45
▸ ADORA2A P29274 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18732401 0.95 MAPT (0.53) ALDH1A1HPGDMAPTKDM4ESMN1; SMN2
SCHEMBL18623308 0.94 MEN1 (0.50) ALDH1A1HPGDMAPTKDM4ESMN1; SMN2
SCHEMBL25682940 0.92 MEN1 (0.46) ALDH1A1HPGDMAPTKDM4ESMN1; SMN2
SCHEMBL17969965 0.91 MEN1 (0.50) ALDH1A1HPGDMAPTKDM4ESMN1; SMN2
SCHEMBL17969961 0.91 MEN1 (0.50) ALDH1A1HPGDMAPTKDM4ESMN1; SMN2
SCHEMBL10051315 0.91 ALDH1A1 (0.50) ALDH1A1HPGDMAPTKDM4ESMN1; SMN2
SCHEMBL18623318 0.90 ALDH1A1 (0.50) ALDH1A1HPGDMAPTKDM4ESMN1; SMN2
SCHEMBL18623322 0.90 MAPT (0.46) ALDH1A1HPGDMAPTKDM4ESMN1; SMN2
SCHEMBL18623359 0.90 ALDH1A1 (0.46) ALDH1A1HPGDMAPTKDM4ESMN1; SMN2
SCHEMBL18623303 0.90 ALDH1A1 (0.50) ALDH1A1HPGDMAPTKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580994-B2 Compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 — — US disclosed
US-20170077414-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-03-16 — — US disclosed
US-20170077414-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-03-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10580994-B2 Compound and organic light-emitting device including the same VDAC1, TMEM109, ELOVL1 ALDH1A1 124/4885HPGD 2887/4885MAPT 1518/4885
US-20170077414-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME VDAC1, TMEM109, ELOVL1 ALDH1A1 124/4885HPGD 2887/4885MAPT 1518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback